WPL06910 - Peritoneal Malignancy Outsourcing - Elective CRS and HIPEC
In plain English
The notice doesn't say
The notice as published
The Trust is seeking a qualified sub-contractor to provide specialised Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) capacity. The service covers complex abdominal surgical oncology for patients with Pseudomyxoma Peritonei (PMP) and Colorectal Peritoneal Metastases (CPM). This is a consultant-led, fully integrated tertiary care sub-contract. Providers must deliver end-to-end pathway care, including pre-operative assessment, surgery, Level 2/3 critical care, inpatient ward care, and discharge management. Site accessibility via major transport hubs to reduce travel burden for patients and families with London support networks. Dedicated on-site or partnered patient relative accommodation to support out-of-region patients and reduce socio-economic barriers for families travelling long distances.